Yvonne McGrath, VP, Research and Development at iTeos Therapeutics, Inc. (ITOS), sold 15,854 shares at $21.92 ($348K) on 2021-05-24, disclosed to the SEC on 2021-06-03.
Open-market sale of $348k ITOS by VP, Research and Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.92 | 7,927 | $174K | 50.0% |
| 2 | $21.92 | 7,927 | $174K | 50.0% |
| Total | $21.92 avg | 15,854 | $348K | 100% |
| Filing → |
| ITOS | SELL | 2021-06-03 | $313K | — | Filing → |
| ITOS | SELL | 2021-05-19 | $389K | — | Filing → |